Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients with Intermediate-Risk Cervical Cancer By Ogkologos - April 7, 2025 767 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a cohort study conducted at Commission on Cancer accredited centres across the US Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Group Dressed as Breasts Gathers to Protest Facebook’s Censorship of Areola... September 2, 2021 2025 ESMO Society Award recipients announced August 5, 2025 FDA Approves Tepotinib for Metastatic Non-Small Cell Lung Cancer February 20, 2024 Selpercatinib Shows Durable Efficacy in RET-Altered Thyroid Cancer August 28, 2020 Load more HOT NEWS Aiming to Prevent Cancer Cases, ESMO Campaigns Against the Use of... A peek behind the scenes: Just how are our funding decisions... EMA Recommends Granting a Conditional Marketing Authorisation for Obecabtagene Autoleucel A celebration of peer review
